Overview: Echinococcus IgG TestIntroduction: The Echinococcus IgG Test detects IgG antibodies to Echinococcus, indicating hydatid disease causing cysts or abdominal pain. Following 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in serology for patients with suspected hydatid disease.
Other Names: Echinococcus Antibody Assay, Hydatid Disease IgG Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Echinococcus antibody testing began in the 1970s with parasitic research. Immunoassays emerged in the 1980s, and by the 2000s, high-sensitivity assays improved accuracy.
Purpose: Diagnoses hydatid disease, guides antiparasitic therapy, and monitors antibody presence in patients with cysts or abdominal pain.
Test Parameters: 1. Echinococcus IgG
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report symptoms like abdominal pain or cysts, and list travel to endemic areas or animal exposure.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document abdominal pain, cysts, or travel to Echinococcus-endemic areas. Include current medications, especially antiparasitics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiparasitic therapy.
Procedural Considerations: Uses an immunoassay to detect Echinococcus IgG antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Cross-reactivity with other parasites may cause false positives. Early infection may cause false negatives.
Clinical Significance: Positive IgG results suggest hydatid disease, prompting imaging or antiparasitic therapy. Negative results may require further testing.
Specialist Consultation: Consult an infectious disease specialist or hepatologist for result interpretation.
Additional Supporting Tests: Echinococcus scolices test, imaging (e.g., ultrasound), or PCR to confirm hydatid disease.
Test Limitations: False positives may occur with related parasites. Results require clinical correlation.
References: IDSA Parasitic Guidelines, 2023; Clinical Infectious Diseases, Brunetti E, 2022.
